Articles
News, editorials, patient stories, and more.
This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or a qualified healthcare provider before making any health decisions. Full Disclaimer
CAR T-Cell Therapy Achieves Full Remission in Patients With Treatment-Resistant Autoimmune Hemolytic Anemia
A clinical study published in the New England Journal of Medicine found that CD19-directed CAR T-cell therapy achieved complete remission in...
Read More — CAR T-Cell Therapy Achieves Full Remission in Patients With Treatment-Resistant Autoimmune Hemolytic Anemia »Emerging Sjögren’s Treatments Show Promise in Clinical Trials
Multiple new drugs targeting immune pathways are showing encouraging results in Sjögren’s clinical trials.
Read More — Emerging Sjögren’s Treatments Show Promise in Clinical Trials »Why Timely Diagnosis of Addison's Disease Is a Life-or-Death Matter
A clinical review in The Journal for Nurse Practitioners highlights why Addison's disease is so frequently missed and what needs to change t...
Read More — Why Timely Diagnosis of Addison's Disease Is a Life-or-Death Matter »ADEM: A Current Look at How the Brain Comes Under Immune Attack and What It Means for Patients
A comprehensive 2026 review synthesizes current understanding of how acute disseminated encephalomyelitis develops, how it is recognized cli...
Read More — ADEM: A Current Look at How the Brain Comes Under Immune Attack and What It Means for Patients »Gut-Derived Toxins May Play a Role in Triggering Hashimoto’s Thyroiditis
Researchers found elevated levels of bacterial toxins in people with Hashimoto’s thyroiditis, suggesting the gut microbiome may influence...
Read More — Gut-Derived Toxins May Play a Role in Triggering Hashimoto’s Thyroiditis »FDA Grants Breakthrough Therapy Status to Ianalumab for Sjögren’s Disease
The FDA has granted Breakthrough Therapy designation to ianalumab, a potential targeted treatment for Sjögren’s disease.
Read More — FDA Grants Breakthrough Therapy Status to Ianalumab for Sjögren’s Disease »Scientists Pinpoint a 'Hot Spot' on the NMDA Receptor That Could Unlock Targeted Treatments for 'Brain on Fire' Disease
Researchers at Oregon Health & Science University have used near-atomic imaging to identify a precise cluster of binding sites on the NMDA r...
Read More — Scientists Pinpoint a 'Hot Spot' on the NMDA Receptor That Could Unlock Targeted Treatments for 'Brain on Fire' Disease »The Treatment Gap Nobody Talks About: Levothyroxine Isn't the Whole Story
A major new review confirms what many patients already suspect: levothyroxine manages the symptoms but does nothing to stop the underlying a...
Read More — The Treatment Gap Nobody Talks About: Levothyroxine Isn't the Whole Story »New Treatments Show Promise in Immune Thrombocytopenia
Emerging therapies improve platelet counts in immune thrombocytopenia.
Read More — New Treatments Show Promise in Immune Thrombocytopenia »An Oral Drug Shows Long-Term Promise for a Rare Form of Autoimmune Angioedema
A December 2025 study in the Journal of Allergy and Clinical Immunology found that long-term treatment with deucrictibant, an oral bradykini...
Read More — An Oral Drug Shows Long-Term Promise for a Rare Form of Autoimmune Angioedema »Case Report: Atypical AMAN Strikes During Active Pneumonia, Prompting Urgent IVIG and Full Recovery
A case published in Cureus in November 2025 describes an unusual presentation of acute motor axonal neuropathy (AMAN) occurring simultaneous...
Read More — Case Report: Atypical AMAN Strikes During Active Pneumonia, Prompting Urgent IVIG and Full Recovery »A Rare Antibody Made This Axonal Neuropathy Nearly Untreatable — Until the Right Diagnosis Was Made
A case report from the University of Texas at San Antonio documents a highly treatment-resistant case of AMSAN in which the discovery of an...
Read More — A Rare Antibody Made This Axonal Neuropathy Nearly Untreatable — Until the Right Diagnosis Was Made »